DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 156 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,908,000 | -7.2% | 144,439 | 0.0% | 0.20% | +10.6% |
| Q2 2021 | $5,288,000 | -41.0% | 144,439 | -27.8% | 0.18% | -10.0% |
| Q1 2021 | $8,968,000 | -21.4% | 200,000 | 0.0% | 0.20% | -26.5% |
| Q4 2020 | $11,414,000 | -11.0% | 200,000 | -20.0% | 0.27% | -44.8% |
| Q3 2020 | $12,825,000 | -32.7% | 250,000 | -21.6% | 0.49% | -32.2% |
| Q2 2020 | $19,046,000 | +32.2% | 318,914 | -8.9% | 0.73% | +8.5% |
| Q1 2020 | $14,410,000 | -48.6% | 350,000 | -22.2% | 0.67% | -40.1% |
| Q4 2019 | $28,008,000 | +4.7% | 450,000 | -42.9% | 1.12% | -31.4% |
| Q3 2019 | $26,762,000 | – | 788,500 | – | 1.63% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $72,236,000 | 20.73% |
| SV Health Investors, LLC | 449,951 | $26,871,000 | 18.64% |
| Redmile Group, LLC | 4,978,941 | $297,342,000 | 5.49% |
| Sunesis Advisors, LLC | 96,299 | $5,751,000 | 5.29% |
| Eversept Partners, LP | 418,652 | $25,001,897 | 3.43% |
| Opaleye Management Inc. | 222,000 | $13,081,000 | 2.64% |
| Avoro Capital Advisors LLC | 1,860,000 | $111,079,000 | 2.20% |
| SPHERA FUNDS MANAGEMENT LTD. | 282,965 | $16,899,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 224,359 | $13,399,000 | 1.23% |
| Artal Group S.A. | 650,000 | $38,818,000 | 1.09% |